A Hospital-Based Registry of Preventive Cardiology Clinics
Launched by NATIONAL INSTITUTE OF CARDIOVASCULAR DISEASES, PAKISTAN · Jul 9, 2024
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding how preventive cardiology clinics can better assess cardiovascular risk and improve health outcomes for patients. Researchers want to find effective ways to use screening tests to evaluate heart health and ultimately reduce the risk of heart-related problems. The goal is to help doctors and patients work together to create personalized treatment plans based on individual risk factors.
Anyone who attends these preventive cardiology clinics may be eligible to participate, as long as they agree to take part in the study. Participants can expect to share their health information and be involved in discussions about their cardiovascular health. It's important to note that individuals who do not wish to give their consent will not be included in the trial. By participating, patients can contribute to valuable research that may lead to better heart health strategies for everyone.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All individuals attending the preventive cardiology clinics.
- Exclusion Criteria:
- • • Individuals who refused to give consent.
About National Institute Of Cardiovascular Diseases, Pakistan
The National Institute of Cardiovascular Diseases (NICVD) in Pakistan is a leading healthcare institution dedicated to the prevention, diagnosis, and treatment of cardiovascular diseases. As a prominent clinical trial sponsor, NICVD is committed to advancing cardiovascular research through rigorous scientific inquiry and innovative therapeutic interventions. The institute collaborates with national and international partners to conduct clinical trials that aim to improve patient outcomes and enhance the understanding of cardiovascular health. With a focus on evidence-based practices, NICVD plays a pivotal role in shaping cardiovascular care in Pakistan and contributing to global health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Karachi, Sindh, Pakistan
Patients applied
Trial Officials
Dr Rubina Rauf
Principal Investigator
National Institute of Cardiovascular Diseases
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported